"For compassionate, high quality cancer services for detection, prevention, and treatment, choose Forrest General's Cancer Center in Hattiesburg, MS. Here, a well-trained, multidisciplinary team maintains a personalized focus on the needs of each individual patient. Our team of oncologists and clinical staff strive to improve the quality and length of life for our patients and continues to further research the cause, prevention, treatment and cure of cancer."

During the past decade, Forrest General Hospital / Cancer Center conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 12 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 9 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Forrest General Hospital / Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 18 trials, followed by "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "Bristol-Myers Squibb" with 3 trials sponsored, "CytomX Therapeutics" with 1 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Forrest General Hospital / Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 5 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Division of Cancer Control" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Forrest General Hospital / Cancer Center" are "Recurrent Breast Carcinoma" (3 trials), "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (3 trials), "Stage II Lung Non-Small Cell Cancer AJCC v7" (3 trials), "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (3 trials) and "Breast Carcinoma" (2 trials). Many other conditions were trialed in "Forrest General Hospital / Cancer Center" in a lesser frequency.

Most popular intervention types in "Forrest General Hospital / Cancer Center" are "Drug" (23 trials), "Other" (20 trials), "Biological" (13 trials), "Procedure" (5 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (11 trials), "Nivolumab" (7 trials), "Carboplatin" (6 trials), "Cisplatin" (6 trials) and "Quality-of-Life Assessment" (6 trials). Other intervention names were less common.

The vast majority of trials in "Forrest General Hospital / Cancer Center" are 24 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Forrest General Hospital / Cancer Center". undefined are not yet recruiting, 4 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Forrest General Hospital / Cancer Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Forrest General Hospital / Cancer Center, 2 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".